Cardiovascular disease remains one of our most urgent health challenges, claiming roughly 3.2 million lives across India each year—accounting for nearly one in four deaths. In my daily practice at Ashok One Hospital, I frequently discuss the primary modifiable driver behind this: elevated low-density lipoprotein (LDL), commonly known as "bad cholesterol". When LDL cholesterol circulates in excess, it deposits along arterial walls, forming rigid plaques that restrict blood flo

Optimizing a traditional Indian diet to lower LDL (bad) cholesterol does not mean giving up familiar, culturally rich meals.

On July 16, 2026, the U.S. FDA marked a significant milestone in cardiovascular medicine by approving Lipfendra (enlicitide). It is the world’s first once-daily oral PCSK9 inhibitor pill.